384 related articles for article (PubMed ID: 28714868)
21. Selective HDAC inhibition for the disruption of latent HIV-1 infection.
Barton KM; Archin NM; Keedy KS; Espeseth AS; Zhang YL; Gale J; Wagner FF; Holson EB; Margolis DM
PLoS One; 2014; 9(8):e102684. PubMed ID: 25136952
[TBL] [Abstract][Full Text] [Related]
22. The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent.
Badia R; Grau J; Riveira-Muñoz E; Ballana E; Giannini G; Esté JA
Antiviral Res; 2015 Nov; 123():62-9. PubMed ID: 26348004
[TBL] [Abstract][Full Text] [Related]
23. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
[TBL] [Abstract][Full Text] [Related]
24. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation.
Beliakova-Bethell N; Mukim A; White CH; Deshmukh S; Abewe H; Richman DD; Spina CA
J Biol Chem; 2019 Apr; 294(14):5576-5589. PubMed ID: 30745362
[TBL] [Abstract][Full Text] [Related]
26. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.
Archin NM; Espeseth A; Parker D; Cheema M; Hazuda D; Margolis DM
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):207-12. PubMed ID: 19239360
[TBL] [Abstract][Full Text] [Related]
27. Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency.
Zerbato JM; Khoury G; Zhao W; Gartner MJ; Pascoe RD; Rhodes A; Dantanarayana A; Gooey M; Anderson J; Bacchetti P; Deeks SG; McMahon J; Roche M; Rasmussen TA; Purcell DF; Lewin SR
EBioMedicine; 2021 Mar; 65():103241. PubMed ID: 33647768
[TBL] [Abstract][Full Text] [Related]
28. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
Søgaard OS; Graversen ME; Leth S; Olesen R; Brinkmann CR; Nissen SK; Kjaer AS; Schleimann MH; Denton PW; Hey-Cunningham WJ; Koelsch KK; Pantaleo G; Krogsgaard K; Sommerfelt M; Fromentin R; Chomont N; Rasmussen TA; Østergaard L; Tolstrup M
PLoS Pathog; 2015 Sep; 11(9):e1005142. PubMed ID: 26379282
[TBL] [Abstract][Full Text] [Related]
29. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
[TBL] [Abstract][Full Text] [Related]
30. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
Spina CA; Anderson J; Archin NM; Bosque A; Chan J; Famiglietti M; Greene WC; Kashuba A; Lewin SR; Margolis DM; Mau M; Ruelas D; Saleh S; Shirakawa K; Siliciano RF; Singhania A; Soto PC; Terry VH; Verdin E; Woelk C; Wooden S; Xing S; Planelles V
PLoS Pathog; 2013; 9(12):e1003834. PubMed ID: 24385908
[TBL] [Abstract][Full Text] [Related]
31. Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412.
Ao Z; Zhu R; Tan X; Liu L; Chen L; Liu S; Yao X
Virol J; 2016 Oct; 13(1):177. PubMed ID: 27769267
[TBL] [Abstract][Full Text] [Related]
32. Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8
Mota TM; McCann CD; Danesh A; Huang SH; Magat DB; Ren Y; Leyre L; Bui TD; Rohwetter TM; Kovacs CM; Benko E; MacLaren L; Wimpelberg A; Cannon CM; Hardy WD; Safrit JT; Jones RB
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051267
[TBL] [Abstract][Full Text] [Related]
33. Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.
Rasmussen TA; Schmeltz Søgaard O; Brinkmann C; Wightman F; Lewin SR; Melchjorsen J; Dinarello C; Østergaard L; Tolstrup M
Hum Vaccin Immunother; 2013 May; 9(5):993-1001. PubMed ID: 23370291
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110α that reactivates latent HIV-1.
Doyon G; Sobolewski MD; Huber K; McMahon D; Mellors JW; Sluis-Cremer N
PLoS One; 2014; 9(1):e84964. PubMed ID: 24489654
[TBL] [Abstract][Full Text] [Related]
35. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
[TBL] [Abstract][Full Text] [Related]
36. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
Ylisastigui L; Coull JJ; Rucker VC; Melander C; Bosch RJ; Brodie SJ; Corey L; Sodora DL; Dervan PB; Margolis DM
J Infect Dis; 2004 Oct; 190(8):1429-37. PubMed ID: 15378435
[TBL] [Abstract][Full Text] [Related]
37. The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function.
Clutton G; Xu Y; Baldoni PL; Mollan KR; Kirchherr J; Newhard W; Cox K; Kuruc JD; Kashuba A; Barnard R; Archin N; Gay CL; Hudgens MG; Margolis DM; Goonetilleke N
Sci Rep; 2016 Aug; 6():30749. PubMed ID: 27480951
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment.
White CH; Beliakova-Bethell N; Lada SM; Breen MS; Hurst TP; Spina CA; Richman DD; Frater J; Magiorkinis G; Woelk CH
Front Immunol; 2018; 9():603. PubMed ID: 29706951
[TBL] [Abstract][Full Text] [Related]
39. Broad activation of latent HIV-1 in vivo.
Barton K; Hiener B; Winckelmann A; Rasmussen TA; Shao W; Byth K; Lanfear R; Solomon A; McMahon J; Harrington S; Buzon M; Lichterfeld M; Denton PW; Olesen R; Østergaard L; Tolstrup M; Lewin SR; Søgaard OS; Palmer S
Nat Commun; 2016 Sep; 7():12731. PubMed ID: 27605062
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
